Serodus ASA is a Scandinavian drug development company, focusing on new therapeutic products for the treatment of diabetes and diabetic comorbidities with large unmet clinical needs.Serodus strives to increase shareholders value through advancing its portfolio to value-creating clinical milestones. With the current drug candidates supported by exceptional competencies to develop them, Serodus is uniquely positioned for success

Biotec Pharmacon is a biopharmaceutical company that develops and manufactures new immunomodulatory products and cold adapted marine enzymes. The company focuses on new and effective solutions within wound care, cancer therapies and other immune related disease areas, and aspires to become a leading supplier of novel enzymes for diagnostics and genetic research.

InDex conducts drug development and is located at Karolinska Institutet Science Park, in Stockholm.

Headquartered in Copenhagen, Sunstone Capital is an early-stage Life Science and Technology venture capital company investing in European start-up companies with strong potential to achieve global success in their markets. Since our establishment in 2007, we have built a strong portfolio currently totaling 50 companies and have completed several successful trade sales and IPOs.

Boynton Angels is a group of Angel investors focused on investing in expansion stage companies in New England with a particular focus on endeavors located within a two-hour radius of Worcester, Massachusetts. Boynton Angels is a member of the Angel Capital Association, following best practice guidelines along with 100 similar organizations in the United States.